• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管紧张素II受体药理学与AT1受体阻滞剂

Angiotensin II receptor pharmacology and AT1-receptor blockers.

作者信息

Chung O, Csikós T, Unger T

机构信息

Institute of Pharmacology, Christian-Albrechts-University, Kiel, Germany.

出版信息

J Hum Hypertens. 1999 Jan;13 Suppl 1:S11-20; discussion S33-4. doi: 10.1038/sj.jhh.1000744.

DOI:10.1038/sj.jhh.1000744
PMID:10076916
Abstract

Angiotensin II (Ang II) has diverse physiological actions leading, for example, to increases in extracellular volume, peripheral vascular resistance and blood pressure, and has also been implicated in the regulation of cell growth and differentiation. Molecular cloning and pharmacological studies have defined two major classes of Ang II receptors, designated as AT1 and AT2. Most effects of Ang II are mediated by AT1 receptors. Much less is known about the physiological role of AT2 receptors. Recent evidence suggests involvement of AT2 receptors in development, cell differentiation, apoptosis and regeneration in various tissues. AT1 and AT2 receptors have been shown to exert counteracting effects on cellular growth and differentiation, vascular tone and the release of arginine vasopressin (AVP). In each condition the AT2 receptor appears to down-modulate actions mediated by the AT1 receptor, resulting in decreased cellular proliferation, decreased levels of serum AVP levels or decreased vasoconstrictor responses. In addition, in neuronal cell lines, the AT2 receptor reportedly exerts antiproliferative effects and promotes neurite outgrowth, an effect accompanied by significant changes in the gene expression pattern of growth- and differentiation-related genes.

摘要

血管紧张素II(Ang II)具有多种生理作用,例如可导致细胞外液量增加、外周血管阻力增加和血压升高,并且还与细胞生长和分化的调节有关。分子克隆和药理学研究已确定了两大类血管紧张素II受体,分别命名为AT1和AT2。血管紧张素II的大多数作用是由AT1受体介导的。对于AT2受体的生理作用了解得要少得多。最近的证据表明,AT2受体参与了各种组织的发育、细胞分化、细胞凋亡和再生过程。已表明AT1和AT2受体对细胞生长和分化、血管张力以及精氨酸加压素(AVP)的释放具有拮抗作用。在每种情况下,AT2受体似乎都会下调由AT1受体介导的作用,从而导致细胞增殖减少、血清AVP水平降低或血管收缩反应减弱。此外,据报道,在神经元细胞系中,AT2受体具有抗增殖作用并促进神经突生长,这一作用伴随着生长和分化相关基因的基因表达模式发生显著变化。

相似文献

1
Angiotensin II receptor pharmacology and AT1-receptor blockers.血管紧张素II受体药理学与AT1受体阻滞剂
J Hum Hypertens. 1999 Jan;13 Suppl 1:S11-20; discussion S33-4. doi: 10.1038/sj.jhh.1000744.
2
Physiological and pharmacological implications of AT1 versus AT2 receptors.
Kidney Int Suppl. 1998 Sep;67:S95-9. doi: 10.1046/j.1523-1755.1998.06719.x.
3
Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.AT1受体拮抗剂氯沙坦、厄贝沙坦和替米沙坦对血管紧张素II诱导的大鼠肠系膜动脉交感神经传递促进作用的影响。
J Cardiovasc Pharmacol. 2001 Jul;38(1):141-8. doi: 10.1097/00005344-200107000-00015.
4
Prejunctional and postjunctional inhibitory actions of eprosartan and candesartan in the isolated rabbit mesenteric artery.依普罗沙坦和坎地沙坦对离体兔肠系膜动脉的节前和节后抑制作用。
J Cardiovasc Pharmacol. 2002 Jul;40(1):50-7. doi: 10.1097/00005344-200207000-00007.
5
The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.血管紧张素、AT1和AT2受体在对中枢血管紧张素的升压、饮水及抗利尿反应中的作用
Brain Res. 1992 Jul 24;586(2):289-94. doi: 10.1016/0006-8993(92)91638-u.
6
Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.AT2受体在年轻自发性高血压大鼠肠系膜小动脉血管紧张素II刺激收缩中的作用
Hypertension. 1999 Jan;33(1 Pt 2):366-72. doi: 10.1161/01.hyp.33.1.366.
7
The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.血管紧张素AT2受体介导冠状动脉内皮细胞中细胞增殖的抑制。
J Clin Invest. 1995 Feb;95(2):651-7. doi: 10.1172/JCI117710.
8
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.血管紧张素II AT1受体拮抗剂。活性代谢物的临床意义。
J Med Chem. 2003 Jun 5;46(12):2261-70. doi: 10.1021/jm0204237.
9
Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.不同来源离体血管中各种血管紧张素Ⅱ1型受体阻滞剂的作用机制差异
Hypertension. 1999 Jun;33(6):1406-13. doi: 10.1161/01.hyp.33.6.1406.
10
Peripheral sympatholytic actions of four AT1 antagonists: are they relevant for long-term antihypertensive efficacy?四种血管紧张素Ⅱ1型受体拮抗剂的外周交感神经阻滞作用:它们与长期降压疗效相关吗?
J Hypertens. 2005 Oct;23(10):1861-7. doi: 10.1097/01.hjh.0000179510.86265.63.

引用本文的文献

1
Unlocking the protective potential of the angiotensin type 2 receptor (ATR) in acute lung injury and age-related pulmonary dysfunction.揭示血管紧张素2型受体(ATR)在急性肺损伤和年龄相关性肺功能障碍中的保护潜力。
Biochem Pharmacol. 2024 Feb;220:115978. doi: 10.1016/j.bcp.2023.115978. Epub 2023 Dec 9.
2
The Pathophysiology of Long COVID throughout the Renin-Angiotensin System.长新冠在肾素-血管紧张素系统中的病理生理学。
Molecules. 2022 May 2;27(9):2903. doi: 10.3390/molecules27092903.
3
Selective Synthesis and Characterization of the Highly Energetic Materials 1-Hydroxy-5H-tetrazole (CHN O), its Anion 1-Oxido-5H-tetrazolate (CN O ) and Bis(1-hydroxytetrazol-5-yl)triazene.
高能量材料1-羟基-5H-四唑(CHN₂O₂)及其阴离子1-氧化-5H-四唑酸根(CN₂O₂⁻)和双(1-羟基四唑-5-基)三氮烯的选择性合成与表征
Chem Asian J. 2021 Oct 4;16(19):3001-3012. doi: 10.1002/asia.202100714. Epub 2021 Sep 2.
4
Upregulation of ERK1/2-eNOS via AT2 receptors decreases the contractile response to angiotensin II in resistance mesenteric arteries from obese rats.通过AT2受体上调ERK1/2-eNOS可降低肥胖大鼠肠系膜阻力动脉对血管紧张素II的收缩反应。
PLoS One. 2014 Aug 29;9(8):e106029. doi: 10.1371/journal.pone.0106029. eCollection 2014.
5
Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine.对于仅使用氨氯地平血压控制不佳的高血压患者,加用缬沙坦比加用氯沙坦更有效。
Vasc Health Risk Manag. 2010 Mar 3;6:87-93. doi: 10.2147/vhrm.s9404.
6
Developmental effect of antenatal exposure to betamethasone on renal angiotensin II activity in the young adult sheep.产前暴露于倍他米松对幼年绵羊肾脏血管紧张素 II 活性的发育影响。
Am J Physiol Renal Physiol. 2010 Apr;298(4):F847-56. doi: 10.1152/ajprenal.00497.2009. Epub 2010 Jan 13.
7
Valsartan in the treatment of heart attack survivors.缬沙坦用于治疗心脏病发作幸存者。
Vasc Health Risk Manag. 2006;2(2):125-38. doi: 10.2147/vhrm.2006.2.2.125.
8
Clinical update: the role of angiotensin II receptor blockers in patients with left ventricular dysfunction (Part II of II).临床最新进展:血管紧张素II受体阻滞剂在左心室功能不全患者中的作用(第二部分)
Clin Cardiol. 2005 Jun;28(6):277-80. doi: 10.1002/clc.4960280604.
9
Modulation of body fluids and angiotensin II receptors in a rat model of intra-uterine growth restriction.宫内生长受限大鼠模型中体液与血管紧张素II受体的调节
J Physiol. 2005 Feb 1;562(Pt 3):937-50. doi: 10.1113/jphysiol.2004.064683. Epub 2004 Nov 11.
10
Irbesartan: an updated review of its use in cardiovascular disorders.厄贝沙坦:关于其在心血管疾病中应用的最新综述。
Drugs. 2000 May;59(5):1187-206. doi: 10.2165/00003495-200059050-00014.